Market Share of Asia-Pacific Cancer Therapy Industry
The cancer therapy market is highly competitive and consists of several players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence, by introducing new products at cheaper prices. The major players include Amgen Inc, AstraZeneca, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Merck & Co., Inc., Lilly, Novartis AG, and Pfizer Inc.
APAC Cancer Therapies Market Leaders
-
Merck & Co. Inc.
-
Bayer AG
-
Amgen Inc
-
AstraZeneca
-
Johnson & Johnson Services, Inc.
*Disclaimer: Major Players sorted in no particular order
